JP2018528210A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528210A5
JP2018528210A5 JP2018511277A JP2018511277A JP2018528210A5 JP 2018528210 A5 JP2018528210 A5 JP 2018528210A5 JP 2018511277 A JP2018511277 A JP 2018511277A JP 2018511277 A JP2018511277 A JP 2018511277A JP 2018528210 A5 JP2018528210 A5 JP 2018528210A5
Authority
JP
Japan
Prior art keywords
body weight
seq
pharmaceutical composition
antibody
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528210A (ja
JP6890340B2 (ja
JP6890340B6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/050183 external-priority patent/WO2017040986A1/en
Publication of JP2018528210A publication Critical patent/JP2018528210A/ja
Publication of JP2018528210A5 publication Critical patent/JP2018528210A5/ja
Publication of JP6890340B2 publication Critical patent/JP6890340B2/ja
Application granted granted Critical
Publication of JP6890340B6 publication Critical patent/JP6890340B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511277A 2015-09-04 2016-09-02 グルカゴン受容体アンタゴニスト抗体を用いた心不全の治療法 Active JP6890340B6 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562214449P 2015-09-04 2015-09-04
US62/214,449 2015-09-04
US201562259061P 2015-11-24 2015-11-24
US62/259,061 2015-11-24
PCT/US2016/050183 WO2017040986A1 (en) 2015-09-04 2016-09-02 Methods for treating heart failure using glucagon receptor antagonistic antibodies

Publications (4)

Publication Number Publication Date
JP2018528210A JP2018528210A (ja) 2018-09-27
JP2018528210A5 true JP2018528210A5 (cg-RX-API-DMAC7.html) 2019-11-28
JP6890340B2 JP6890340B2 (ja) 2021-06-18
JP6890340B6 JP6890340B6 (ja) 2021-07-14

Family

ID=58188491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511277A Active JP6890340B6 (ja) 2015-09-04 2016-09-02 グルカゴン受容体アンタゴニスト抗体を用いた心不全の治療法

Country Status (7)

Country Link
US (2) US10765737B2 (cg-RX-API-DMAC7.html)
EP (1) EP3344279B1 (cg-RX-API-DMAC7.html)
JP (1) JP6890340B6 (cg-RX-API-DMAC7.html)
CN (1) CN108348582B (cg-RX-API-DMAC7.html)
AU (1) AU2016318097B2 (cg-RX-API-DMAC7.html)
CA (1) CA2999747A1 (cg-RX-API-DMAC7.html)
WO (1) WO2017040986A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7005638B2 (ja) 2017-01-27 2022-02-04 エヌジーエム バイオファーマシューティカルス,インコーポレーテッド グルカゴン受容体結合タンパク質及びその使用方法
EP3829636A1 (en) 2018-07-27 2021-06-09 NGM Biopharmaceuticals, Inc. Use of glucagon receptor antagonists with immunotherapeutic agent
JP7840511B2 (ja) 2019-02-01 2026-04-06 石▲薬▼集▲団▼巨石生物制▲薬▼有限公司 抗クローディン18抗体及びそれらの使用の方法
CN118393150B (zh) * 2024-06-27 2024-09-13 潍坊市润生畜禽良种有限公司 一种优化gcgr卵黄抗体制备的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030103983A1 (en) 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
WO2006005469A2 (en) 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with glucagon receptor (gcgr)
CL2007002668A1 (es) * 2006-09-20 2008-05-09 Amgen Inc Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
US9034883B2 (en) * 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US8771696B2 (en) 2010-11-23 2014-07-08 Regeneron Pharmaceuticals, Inc. Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor

Similar Documents

Publication Publication Date Title
JP2020517287A5 (cg-RX-API-DMAC7.html)
JP5855569B2 (ja) 破骨細胞特異的抗原の生物学的活性を特異的にブロックする抗体
JP2018517431A5 (cg-RX-API-DMAC7.html)
JP2017515909A5 (cg-RX-API-DMAC7.html)
JP2017504578A5 (cg-RX-API-DMAC7.html)
JP2020534830A5 (cg-RX-API-DMAC7.html)
JP2020522513A5 (cg-RX-API-DMAC7.html)
JP2017149720A5 (cg-RX-API-DMAC7.html)
JP2011528561A5 (cg-RX-API-DMAC7.html)
JP2020525032A5 (cg-RX-API-DMAC7.html)
JP2018121657A5 (cg-RX-API-DMAC7.html)
JP2017500018A5 (cg-RX-API-DMAC7.html)
JP2018521638A5 (cg-RX-API-DMAC7.html)
JP2009518005A5 (cg-RX-API-DMAC7.html)
JP2010526028A5 (cg-RX-API-DMAC7.html)
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
JP2010502183A5 (cg-RX-API-DMAC7.html)
JP2011526249A5 (cg-RX-API-DMAC7.html)
JP2021502984A5 (cg-RX-API-DMAC7.html)
JP2007262074A5 (cg-RX-API-DMAC7.html)
RU2016133463A (ru) Гуманизированные антитела с повышенной стабильностью
RU2010149746A (ru) Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
JP2016536322A5 (cg-RX-API-DMAC7.html)
JP2015535691A5 (cg-RX-API-DMAC7.html)
JP2015506912A5 (cg-RX-API-DMAC7.html)